Vimarsana.com

Latest Breaking News On - Evoke pharma daily - Page 1 : vimarsana.com

Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Grows By 6.0%

Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 40,700 shares, an increase of 6.0% from the April 30th total of 38,400 shares. Approximately 0.6% of the company’s shares are sold short. Based on an […]

Nasdaq
Pharma-inc
Evoke-pharma
Get-free-report
Evoke-pharma-daily

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Tuesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.1 % EVOK opened at $0.43 on Tuesday. The company has a market cap of $3.71 million, a price-to-earnings ratio […]

Pharma-inc
Pharma-company-profile
Evoke-pharma
Free-report
Pharma-trading-down
Get-free-report
Evoke-pharma-daily

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.1 % NASDAQ EVOK opened at $0.43 on Tuesday. The stock has a market cap of $3.71 million, a […]

Pharma-inc
Evoke-pharma
Free-report
Pharma-trading-down
Get-free-report
Evoke-pharma-daily

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc
Nasdaq
Evoke-pharma
Free-report
Get-free-report
Evoke-pharma-daily

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc
Evoke-pharma
Free-report
Get-free-report
Evoke-pharma-daily

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc
Evoke-pharma
Free-report
Get-free-report
Evoke-pharma-daily

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc
Pharma-company-profile
Evoke-pharma
Free-report
Get-free-report
Evoke-pharma-daily

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc
Evoke-pharma
Free-report
Get-free-report
Evoke-pharma-daily

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.com

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc
Evoke-pharma
Free-report
Get-free-report
Evoke-pharma-daily

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report published on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 2.2 % NASDAQ:EVOK opened at $0.47 on Thursday. Evoke Pharma has a twelve month low of $0.42 and a twelve month […]

Pharma-inc
Nasdaq
Evoke-pharma
Free-report
Pharma-trading-down
Get-free-report
Evoke-pharma-daily
Nasdaq-evok
Revok
Medical
Initiated-coverage

vimarsana © 2020. All Rights Reserved.